Systemic chemotherapy for patients with bladder cancer – current controversies and future directions
- 30 June 2004
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 30 (4), 343-358
- https://doi.org/10.1016/j.ctrv.2003.12.005
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector InstillationJournal of Clinical Oncology, 2002
- A feasibility study of carboplatin with fixed dose of gemcitabine in ‘unfit’ patients with advanced bladder cancerEuropean Journal Of Cancer, 2001
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001
- Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?Journal of Virology, 2001
- A Novel, Conditionally Replicative Adenovirus for the Treatment of Breast Cancer That Allows Controlled Replication of E1a-Deleted Adenoviral VectorsHuman Gene Therapy, 2000
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- Adjuvant Chemotherapy in T3 Carcinoma of the Bladder A Prospective Trial: Preliminary ReportBritish Journal of Urology, 1988
- Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with RadiotherapyBritish Journal of Urology, 1983